Note Bibliografiche

Questo articolo, disponibile in formato pdf e consultabile gratuitamente, presenta in modo chiaro e dettagliato il quadro relativo alla Malattia di Stargardt.

Curiosità: La malattia porta il nome di Karl Stargardt, oftalmologo tedesco che nel 1909 per primo la osservò e la descrisse. [Stargardt K. Uber familiare, progressive degeenration under makulagegend des augen. Albrecht von Graefes Arch Ophthalmol. 1909;71:534–50.]

Di seguito i riferimenti bibliografici più importanti riferiti a quanto descritto in questa sezione.

  • Stargardt K. Uber familiare, progressive degeenration under makulagegend des augen. Albrecht von Graefes Arch Ophthalmol. 1909;71:534–50.
  • Noble KG, Carr RE. Stargardt’s disease and fundus flavimaculatus. Arch Ophthalmol. 1979;97:1281–5.
  • Walia S, Fishman GA. Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet. 2009;30:63–8.
  • Weleber RG. Stargardt’s macular dystrophy. Arch Ophthalmol. 1994;112:752–4.
  • Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–14.
  • Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–14.
  • Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110:1151–8.
  • Fishman GA, Farbman JS, Alexander KR. Delayed rod dark adaptation in patients with Stargardt’s disease. Ophthalmology. 1991;98:957–62.
  • Moloney JB, Mooney DJ, O’Connor MA. Retinal function in Stargardt’s disease and fundus flavimaculatus. Am J Ophthalmol. 1983;96:57–65.
  • Mantyjarvi M, Tuppurainen K. Color vision in Stargardt’s disease. Int Ophthalmol. 1992;16:423–8.
  • Birnbach CD, Jarvelainen M, Possin DE, Milam AH. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101:1211–9.
  • Steinmetz RL, Garner A, Maguire JI, Bird AC. Histopathology of incipient fundus flavimaculatus. Ophthalmology. 1991;98:953–6.
  • Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt’s disease–Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1995;36:2327–31.
  • Eldred GE, Lasky MR. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361:724–6.
  • Fish G, Grey R, Sehmi KS, Bird AC. The dark choroid in posterior retinal dystrophies. Br J Ophthalmol. 1981;65:359–63.
  • Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119:359–69. [PubMed]
  • Lois N, Holder GE, Fitzke FW, Plant C, Bird AC. Intrafamilial variation of phenotype in Stargardt macular dystrophy-Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1999;40:2668–75.
  • Genead MA, Fishman GA, Stone EM, Allikmets R. The Natural History of Stargardt Disease with Specific Sequence Mutation in the ABCA4 Gene. Invest Ophthalmol Vis Sci. 2009
  • Franceschetti AF,J. Fundus flavimaculatus. Arch Ophthalmol. 1965;25:505–30.
  • Hadden OB, Gass JD. Fundus flavimaculatus and Stargardt’s disease. Am J Ophthalmol. 1976;82:527–39.
  • Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, et al. A gene for Stargardt’s disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet. 1993;5:308–11.
  • Westerfeld C, Mukai S. Stargardt’s disease and the ABCR gene. Semin Ophthalmol. 2008;23:59–65.